AVXL
Price
$7.75
Change
+$0.44 (+6.03%)
Updated
Nov 5, 04:54 PM (EDT)
20 days until earnings call
CRVO
Price
$12.29
Change
-$0.18 (-1.44%)
Updated
Nov 5, 04:00 PM (EDT)
Ad is loading...

AVXL vs CRVO

Header iconAVXL vs CRVO Comparison
Open Charts AVXL vs CRVOBanner chart's image
Anavex Life Sciences
Price$7.75
Change+$0.44 (+6.03%)
Volume$3.1K
CapitalizationN/A
CervoMed
Price$12.29
Change-$0.18 (-1.44%)
Volume$6.09K
CapitalizationN/A
View a ticker or compare two or three
AVXL vs CRVO Comparison Chart
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CRVO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AVXL vs. CRVO commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Buy and CRVO is a Buy.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (AVXL: $7.29 vs. CRVO: $12.55)
Brand notoriety: AVXL and CRVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 252% vs. CRVO: 68%
Market capitalization -- AVXL: $618.16M vs. CRVO: $103.58M
AVXL [@Biotechnology] is valued at $618.16M. CRVO’s [@Biotechnology] market capitalization is $103.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileCRVO’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • CRVO’s FA Score: 0 green, 5 red.
According to our system of comparison, AVXL is a better buy in the long-term than CRVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 5 TA indicator(s) are bullish while CRVO’s TA Score has 4 bullish TA indicator(s).

  • AVXL’s TA Score: 5 bullish, 5 bearish.
  • CRVO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CRVO is a better buy in the short-term than AVXL.

Price Growth

AVXL (@Biotechnology) experienced а +26.12% price change this week, while CRVO (@Biotechnology) price change was -4.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.90%.

Reported Earning Dates

AVXL is expected to report earnings on Feb 06, 2025.

CRVO is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($618M) has a higher market cap than CRVO($104M). CRVO YTD gains are higher at: 64.482 vs. AVXL (-21.697). CRVO has higher annual earnings (EBITDA): -5.1M vs. AVXL (-41.47M). AVXL has more cash in the bank: 139M vs. CRVO (45.1M). CRVO has less debt than AVXL: CRVO (0) vs AVXL (88.2K). AVXL (0) and CRVO (0) have equivalent revenues.
AVXLCRVOAVXL / CRVO
Capitalization618M104M594%
EBITDA-41.47M-5.1M812%
Gain YTD-21.69764.482-34%
P/E RatioN/A5.43-
Revenue00-
Total Cash139M45.1M308%
Total Debt88.2K0-
FUNDAMENTALS RATINGS
AVXL vs CRVO: Fundamental Ratings
AVXL
CRVO
OUTLOOK RATING
1..100
859
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
9493
PRICE GROWTH RATING
1..100
3956
P/E GROWTH RATING
1..100
10061
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVO's Valuation (45) in the Biotechnology industry is in the same range as AVXL (50). This means that CRVO’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (78) in the Biotechnology industry is in the same range as CRVO (100). This means that AVXL’s stock grew similarly to CRVO’s over the last 12 months.

CRVO's SMR Rating (93) in the Biotechnology industry is in the same range as AVXL (94). This means that CRVO’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Price Growth Rating (39) in the Biotechnology industry is in the same range as CRVO (56). This means that AVXL’s stock grew similarly to CRVO’s over the last 12 months.

CRVO's P/E Growth Rating (61) in the Biotechnology industry is somewhat better than the same rating for AVXL (100). This means that CRVO’s stock grew somewhat faster than AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLCRVO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CRVO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNEFF2.480.10
+4.20%
Bonterra Energy Corp.
REPYY12.820.25
+1.99%
Repsol S.A.
SRNW0.14N/A
+0.14%
Stratos Renewables Corp.
DASTF34.81N/A
N/A
Dassault Systemes SA
ORKLY9.39-0.02
-0.21%
Orkla ASA

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with CORT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then CORT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+6.66%
CORT - AVXL
53%
Loosely correlated
+5.14%
MDXG - AVXL
51%
Loosely correlated
+2.89%
NTLA - AVXL
48%
Loosely correlated
+2.30%
TENX - AVXL
47%
Loosely correlated
+0.33%
BEAM - AVXL
47%
Loosely correlated
+6.24%
More

CRVO and

Correlation & Price change

A.I.dvisor tells us that CRVO and VIRX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRVO and VIRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
-2.03%
VIRX - CRVO
28%
Poorly correlated
+4.35%
VKTX - CRVO
27%
Poorly correlated
-13.37%
NKTR - CRVO
27%
Poorly correlated
+8.94%
AVXL - CRVO
27%
Poorly correlated
+6.66%
FATE - CRVO
25%
Poorly correlated
+13.58%
More